Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
68.78
-2.23 (-3.14%)
Jul 11, 2025, 2:29 PM - Market open
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Mar 31, 2025 | 134.75B | 536.00M |
| Dec 31, 2024 | 127.72B | 620.00M |
| Sep 30, 2024 | 117.71B | 661.00M |
| Jun 30, 2024 | 110.96B | 504.00M |
| Mar 31, 2024 | 106.68B | 2.74B |
| Dec 31, 2023 | 99.62B | 2.95B |
| Sep 30, 2023 | 90.58B | 2.32B |
| Jun 30, 2023 | 82.01B | 4.15B |
| Mar 31, 2023 | 75.18B | 5.49B |
| Dec 31, 2022 | 67.40B | 7.41B |
| Sep 30, 2022 | 62.27B | 9.09B |
| Jun 30, 2022 | 57.17B | 9.26B |
| Mar 31, 2022 | 53.45B | 9.36B |
| Dec 31, 2021 | 49.54B | 9.11B |
| Sep 30, 2021 | 46.78B | 9.41B |
| Jun 30, 2021 | 43.48B | 10.27B |
| Mar 31, 2021 | 42.76B | 10.05B |
| Dec 31, 2020 | 43.74B | 10.38B |
| Sep 30, 2020 | 43.65B | 11.17B |
| Jun 30, 2020 | 44.31B | 10.63B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.